期刊文献+

中西药联合治疗过敏性紫癜的疗效观察 被引量:6

Clinical Study of Traditional Chinese Medicine Combined with Western Medicine in Treating Anaphylactoid Purpura
下载PDF
导出
摘要 目的观察中西药联合治疗过敏性紫癜的疗效。方法治疗组42例在西医常规治疗同时,按照中医辨证分型,分为血热妄行型、气不摄血型,分别采用清热、凉血、益气、止血等方法治疗,2周为1个疗程。用药4周后观察疗效。结果治疗组有效率85.7%,对照组有效率65.0%。2组有效率比较差异有统计学意义。结论中西药联合治疗过敏性紫癜临床疗效满意。 Objective To observe the curative effect of traditional Chinese medicine(TCM) combined with western medicine in treating patients with anaphylactoid purpura.Methods 42 cases in treatment group were given routine treatment of western medicine,and at the same time they were classified into type of frenetic movement of blood due to heat and type of qi failing to control the blood according to TCM syndrome differentiation.And then they were treated with therapies of clearing heat,cooling blood,tonifying qi and stopping bleeding.One therapeutic course was two weeks.The curative effect was observed four weeks after the treatment.Results The total effective rate in the treatment group and control group were 85.7% and 65.0% respectively.The difference between two groups was statistically significant.Conclusion The clinical effect of TCM combined with western medicine in treating patients with anaphylactoid purpura was satisfactory.
出处 《中国中西医结合皮肤性病学杂志》 CAS 2012年第4期232-233,共2页 Chinese Journal of Dermatovenereology of Integrated Traditional and Western Medicine
关键词 过敏性紫癜 中西医结合疗法 疗效观察 anaphylactoid purpura combined therapy of traditional Chinese medicine and western medicine clinical efficacy
  • 相关文献

参考文献5

二级参考文献33

  • 1张强,杨达胜.麦考酚酸酯治疗儿童顽固性过敏性紫癜[J].中国药师,2004,7(12):954-955. 被引量:2
  • 2王墨,李秋,王晓刚,吴道奇.大剂量环磷酰胺冲击治疗儿童严重过敏性紫癜肾炎疗效观察[J].中国药业,2005,14(5):64-65. 被引量:15
  • 3高玉兴,池永学,李亚荣,尹永杰,刘禹仁.过敏性紫癜白细胞介素2水平及其受体表达[J].中华儿科杂志,1995,33(2):91-92. 被引量:39
  • 4关凤军,易著文,党西强,何庆南,吴小川,何小解,黄丹琳.儿童过敏性紫癜早期应用糖皮质激素预防肾损害Meta分析[J].中国循证儿科杂志,2006,1(4):258-263. 被引量:48
  • 5Namgoong MK, Lim BK, Kim JS. Eosinophil Cationic protein in Henoch-Schonlein purpura and in IgA nephropathy [J]. Pediatr Nephrol, 1997,11 (6) : 703-706.
  • 6Amoli MM, Thomson W, Hajee AH, et al. Interlenkin 8 gene polymorphism is associated with increased risk of nephritis in cutaneous vasculitis [ J ]. T Rheumatol, 2002,29 ( 11 ) : 2367-2370.
  • 7Rostoker G, Rymer Jc, Bagnard G, et al. Imbalances in serum proinflammatory cytokines and their soluble receptors a putative role in the progression of idiopathic IgA nephropathy (IgAN)and Henoch-Schonlein purpura nephritis and a potential target of immunoglobulin the therapy [J]. J Clin Exp Immunol, 1998, 114 ( 3 ) : 468-476.
  • 8Coppo R, Mazzucco G, Cagnoli L, et al. Long-term prognosis of Henoch-Schonlein nephritis in adults and children [J]. Nephrol Dial Transpl, 1997,115 (3) : 267-268.
  • 9Egan CA, Taylor TB, Meyer LJ, et al. IgA1 is the major IgAsubclass in cutaneous blood vessels in Henoch-Schonlein purpura [J ]. Br J Dematol, 1999,14(5) : 859-862.
  • 10Saulsbury FT. Henoch-Schonlein purpura [J]. Pediatr Sermatol, 1984,12( 1 ) : 195-201.

共引文献40

同被引文献64

引证文献6

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部